MNI BRIEF: China Supports Globalisation Despite Turbulence

MNI: PBOC Net Injects CNY11.0 Bln via OMO Tuesday

MNI: PBOC Sets Yuan Parity Lower At 7.1910 Tues; -1.46% Y/Y

MNI China Daily Summary: Monday, November 25

MNI: China CFETS Yuan Index Up 0.01% In Week of Nov 22

MNI: PBOC Net Injects CNY76.7 Bln via OMO Monday

MNI: UK NOV BRC SHOP PRICES +0.2% M/M, -0.6% Y/Y

MNI: JAPAN OCT SERVICES PPI +2.9% Y/Y; SEPT REV +2.8%

EZ/UK T-Bill Calendar: 2/3-Month ATB Auction on Tuesday

AUSTRALIA: 2025 Election Outcome Looking More Uncertain According To Newspoll

MNI EXCLUSIVE: German Turmoil Dashes EU's Joint-Funding Hopes -Officials

© 1982-2024 MNI. All rights reserved.
Terms | Privacy
Log Out
Free Trial

Putin: India And Russia May Begin Producing Sputnik V COVID-19 Vaccine

RUSSIA

Russian President Vladimir Putin has stated that China and India may begin producing the Sputnik V COVID-19 vaccine, according to state news agency RIA.

  • The offer of allowing India and China to produce Sputnik V entrenches the view that Russia is seeking to develop the creation of an effective COVID-19 vaccine into a form of 'vaccine race', pitting the West against the East, rather than as a collaborative global effort.
  • The offer of production rights to China may be rejected, given that Chinese firm Sinovac Biotech is believed to be in the stage III trials for its vaccine, as is Sinopharm. Many Chinese workers are believed to have already received the candidate vaccine before regulatory approval or the conclusion of clinical trials.
EM BulletHomepagemarkets-real-timePolitical RiskEmerging Market NewsPolitical Risk BulletBulletMarketsFixed Income BulletsForeign Exchange Bullets
EM BulletHomepagemarkets-real-timePolitical RiskEmerging Market NewsPolitical Risk BulletBulletMarketsFixed Income BulletsForeign Exchange Bullets

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.